rucaparib
clovis
['ovarian', 'rucaparib', 'gyn']
maintenance rucaparib induced a progression-free survival improvement in patients with newly diagnosed ovarian cancer compared with placebo, which was also seen across all prespecified subgroups. #gyncsm #esmo2022 | 
Oncology news and insights from leading researchers and cancer centers.